China, Sept. 9 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Application of Molecular Consultation in the Diagnosis and Treatment of Neurogenetic Metabolic Diseases'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600131998
Registration Time: 2026/09/08
Type: Observational study
Primary Sponsor: Xuanwu Hospital Capital Medical University
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=342085
Published by HT Digital Content Services with permission from Health Daily Digest....